Search research articles
Contact Us
Filters
Showing results (1-10 of 357) with videos related to
Page
of 36
Sort By:
Pediatria Polska
|
November 1, 1995
[Clear cell carcinoma of the kidney in an 8-year-old boy]
M Bukowski
Expert Opinion on Investigational Drugs
|
July 29, 2003
AE-941, a multifunctional antiangiogenic compound: trials in renal cell carcinoma
Ronald M Bukowski
Oncology (Williston Park, N.Y.)
|
June 16, 2006
Targeted therapy for cytokine-refractory metastatic renal cell carcinoma, and treatment in the community
Ronald M Bukowski
Cancer
|
October 8, 1997
Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2
R M Bukowski
Cancer
|
April 30, 2009
Prognostic factors for survival in metastatic renal cell carcinoma: update 2008
Ronald M Bukowski
Expert Opinion on Pharmacotherapy
|
July 1, 2010
Systemic therapy for metastatic renal cell carcinoma in treatment naïve patients: a risk-based approach
Ronald M Bukowski
Cancer Management and Research
|
September 21, 2011
Critical appraisal of pazopanib as treatment for patients with advanced metastatic renal cell carcinoma
Ronald M Bukowski
Child Development
|
October 1, 1990
Age differences in children's memory of information about aggressive, socially withdrawn, and prosociable boys and girls
W M Bukowski
The Urologic Clinics of North America
|
February 1, 1993
Management of advanced and extragonadal germ-cell tumors
R M Bukowski
Expert Review of Anticancer Therapy
|
May 18, 2010
Pazopanib: a multikinase inhibitor with activity in advanced renal cell carcinoma
Ronald M Bukowski
Page
of 36
Search research articles
Search
Showing results (1-10 of 357) with videos related to
Sort By:
Page
of 36
Pediatria Polska
|
November 1, 1995
[Clear cell carcinoma of the kidney in an 8-year-old boy]
M Bukowski
Expert Opinion on Investigational Drugs
|
July 29, 2003
AE-941, a multifunctional antiangiogenic compound: trials in renal cell carcinoma
Ronald M Bukowski
Oncology (Williston Park, N.Y.)
|
June 16, 2006
Targeted therapy for cytokine-refractory metastatic renal cell carcinoma, and treatment in the community
Ronald M Bukowski
Cancer
|
October 8, 1997
Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2
R M Bukowski
Cancer
|
April 30, 2009
Prognostic factors for survival in metastatic renal cell carcinoma: update 2008
Ronald M Bukowski
Expert Opinion on Pharmacotherapy
|
July 1, 2010
Systemic therapy for metastatic renal cell carcinoma in treatment naïve patients: a risk-based approach
Ronald M Bukowski
Cancer Management and Research
|
September 21, 2011
Critical appraisal of pazopanib as treatment for patients with advanced metastatic renal cell carcinoma
Ronald M Bukowski
Child Development
|
October 1, 1990
Age differences in children's memory of information about aggressive, socially withdrawn, and prosociable boys and girls
W M Bukowski
The Urologic Clinics of North America
|
February 1, 1993
Management of advanced and extragonadal germ-cell tumors
R M Bukowski
Expert Review of Anticancer Therapy
|
May 18, 2010
Pazopanib: a multikinase inhibitor with activity in advanced renal cell carcinoma
Ronald M Bukowski
Page
of 36